Conquering Diseases

Investigational Study for Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (ANVIL)


Seeking patients who have taken part in the ALCHEMIST Screening Trial to determine mutational status


The purpose is to find out whether adding a new drug after surgery and the usual postoperative treatment can stop lung cancer from coming back.

What we're hoping for

We are hoping that the study drug may turn on the immune system to attack cancer cells left behind after surgery

Additional Information Identifier: NCT02595944

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655